Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep;20(6):1695-1704.
doi: 10.1007/s11739-025-04091-2. Epub 2025 Aug 28.

Opioid-induced constipation in internal medicine: recognition and management pathways

Affiliations
Review

Opioid-induced constipation in internal medicine: recognition and management pathways

Piero Portincasa et al. Intern Emerg Med. 2025 Sep.

Abstract

Opioid-induced constipation (OIC) remains one of the most frequent and distressing gastrointestinal side effects encountered by patients on chronic opioid therapy. Despite the high prevalence, OIC is frequently underdiagnosed and inadequately managed, with critical effects on the quality of life of patients. Aim of this review is to promote the awareness about OIC in the context of internal medicine. We examined the statement EnhanCing Healthcare Outcomes in Opioid-Induced Constipation (ECHO OIC) by European experts to streamline the diagnosis and management of OIC in clinical practice. Such guidelines have been further discussed by an Italian expert consensus to provide national customization and a multidisciplinary approach. The key finding is the implementation of a multi-step clinical pathway for prevention, diagnosis, treatment, and long-term management of OIC, taking into account the improvement of quality of life of patients. In conclusion, we urge to expand awareness about OIC. The seven-step diagnostic-therapeutic pathway approach formulated by ECHO OIC is a pragmatic and scalable model to improve OIC management with emphasis on education, early intervention, monitoring, tailored pharmacologic strategies, and coordinated referral when necessary.

Keywords: Bristol stool scale; Gut transit; Laxatives; Naldemedine; Polyethylene glycol; Rome IV criteria.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: All the authors report having no relevant conflicts of interest for this article. Human and animal rights statement and Informed consent: Not applicable

Figures

Fig. 1
Fig. 1
Chemical formulas of three PAMORAs: Methylnaltrexone, Naloxegol and Naldemedine

References

    1. Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden JB, Martin BC (2008) Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 138(2):440–449. 10.1016/j.pain.2008.04.027 - PMC - PubMed
    1. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN (2015) Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 156(4):569–576. 10.1097/01.j.pain.0000460357.01998.f1 - PubMed
    1. Bosetti C, Santucci C, Radrezza S, Erthal J, Berterame S, Corli O (2019) Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990–2016. Eur J Pain 23(4):697–707. 10.1002/ejp.1337 - PubMed
    1. Szigethy E, Knisely M, Drossman D (2018) Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol 15(3):168–180. 10.1038/nrgastro.2017.141 - PMC - PubMed
    1. Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O’Brien T, Morlion B, Tack J (2019) Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United Eur Gastroenterol J 7(1):7–20 - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources